CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net Loss	$ (173,715)	$ (33,866)
Adjustments to reconcile net loss to net cash used in operating activities:
Credit loss expense	3,980	1,153
Depreciation and amortization	19,749	19,765
Amortization of financing costs charged to interest expense	1,235	1,234
Amortization of right-of-use assets	1,627	2,807
Gain on debt extinguishment	(13,017)	0
Stock-based compensation expense	31,694	29,956
Impairment of goodwill and intangible assets	131,595	0
Change in contingent consideration	(110)	15,044
Other non-cash income, net	(4,136)	(613)
Change in operating assets and liabilities:
Accounts receivable	12,909	10,991
Prepaid expenses and other assets	(229)	1,114
Accounts payable	820	(265)
Other accrued expenses	(3,192)	(10,282)
Partner Share liability	(18,330)	(4,994)
Consumer Incentive liability	(2,903)	(5,075)
Net cash used in operating activities	(11,803)	(3,119)
Investing activities
Acquisition of property and equipment	(1,439)	(393)
Capitalized software development costs	(13,423)	(8,302)
Business divestiture	202	0
Net cash used in investing activities	(14,660)	(8,695)
Financing activities
Proceeds from issuance of debt	172,500	30,000
Settlement of contingent consideration	14,167	50,050
Principal payment of debt	(199,291)	(21)
Proceeds from termination of capped calls related to convertible notes	115	0
Proceeds from issuance of common stock	48,634	55
Equity issuance costs	(309)	(58)
Debt issuance costs	(5,836)	0
Net cash provided by (used in) financing activities	1,646	(20,074)
Effect of exchange rates on cash, cash equivalents and restricted cash	(25)	43
Net decrease in cash, cash equivalents and restricted cash	(24,842)	(31,845)
Cash, cash equivalents, and restricted cash — Beginning of period	91,830	121,985
Cash, cash equivalents, and restricted cash — End of period	66,988	90,140
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet:
Cash and cash equivalents	66,988	90,067
Restricted cash	0	73
Total cash, cash equivalents and restricted cash — End of period	66,988	90,140
Supplemental disclosure of cash flow information:
Cash paid for interest	2,453	2,958
Amounts accrued for property and equipment	20	0
Amounts accrued for capitalized software development costs	203	0
Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below)	$ 27,451	$ 0